SGLT-2 Inhibitors: Fighting Cardiovascular Disease Mortality in Diabetes

被引:0
|
作者
Ghaffar, Zunaira Abdul
Anwar, Shahzad
Rizvi, Syed Wajih
机构
[1] Dow Univ Hlth Sci, Dept Med, Dow Med Coll, Karachi, Pakistan
[2] Univ Med & Dent, Camden, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:195 / 195
页数:1
相关论文
共 50 条
  • [21] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [22] Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
    Pishdad, Reza
    Auwaerter, Paul G.
    Kalyani, Rita R.
    CURRENT DIABETES REPORTS, 2024, 24 (05) : 108 - 117
  • [23] Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
    Reza Pishdad
    Paul G. Auwaerter
    Rita R. Kalyani
    Current Diabetes Reports, 2024, 24 : 108 - 117
  • [24] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Claire C. J. Dekkers
    Ron T. Gansevoort
    Hiddo J. L. Heerspink
    Current Diabetes Reports, 2018, 18
  • [25] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Dekkers, Claire C. J.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [26] The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
    Gillard, Pieter
    Schnell, Oliver
    Groop, Per-Henrik
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [27] The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
    Riggs, Kayla
    Ali, Hiba
    Taegtmeyer, Heinrich
    Gutierrez, Absalon D.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (07) : 292 - 297
  • [28] Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
    Santos, Leyna Leite
    Camello De Lima, Fernando Jose
    De Sousa-Rodrigues, Celio Fernando
    Barbosa, Fabiano Timbo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 636 - 641
  • [29] The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease
    Wassim Mosleh
    Abhinav Sharma
    Mandeep S. Sidhu
    Brian Page
    Umesh C. Sharma
    Michael E. Farkouh
    Cardiovascular Drugs and Therapy, 2017, 31 : 311 - 318
  • [30] The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease
    Mosleh, Wassim
    Sharma, Abhinav
    Sidhu, Mandeep S.
    Page, Brian
    Sharma, Umesh C.
    Farkouh, Michael E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (03) : 311 - 318